Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypertension × Sunitinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Renal Cell 72 Neoplasms 22 Kidney Neoplasms 20 Gastrointestinal Stromal Tumors 16 Breast Neoplasms 16 Carcinoma, Non-Small-Cell Lung 14 Neoplasm Metastasis 11 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 6 Lung Neoplasms 6 Colorectal Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Solid Tumors 5 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Glioblastoma 5 Brain Neoplasms 5 Sarcoma 4 Neuroendocrine Tumors 4 Melanoma 4 Esophageal Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma 4 Astrocytoma 4 Adenoma, Islet Cell 4 Thyroid Cancer, Papillary 3 Thymoma 3 Sarcoma, Alveolar Soft Part 3

Interventions

relacorilant 4 Hydrochlorothiazide 4 Nutrition Assessment 2 Labetalol 2 Bevacizumab 2 Angiotensin-Converting Enzyme Inhibitors 2 Amlodipine 2 ziprasidone 1 sacubitril and valsartan sodium hydrate drug combination 1 pembrolizumab 1 fimasartan 1 enzalutamide 1 clevidipine 1 bicalutamide 1 aliskiren 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Thiazides 1 Therapeutics 1 Surveys and Questionnaires 1 Sunitinib 1 Sulindac 1 Spironolactone 1 Sevelamer 1 Rocuronium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Charite University, Berlin, Germany

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon ⚡